Discover advanced skincare supplied exclusively to clinics, medical professionals, and distributors.

Restore luminosity and firmness with professional‑grade solutions delivered by a trusted medical supplier.

Scientific Insight. Distributor‑Ready Outcomes.

At ROVOCCI, our regenerative and aesthetic solutions are supplied to distributors with a strong scientific foundation behind every formulation. As a dedicated supplier, we provide high‑quality, data‑driven products that help partners build reliable portfolios and support consistent results across diverse markets.

  • +94%

    ENHANCED HYDRATION SUPPORT*

    Formulations enriched with hyaluronic acid and polynucleotides designed to support increased skin moisture.

  • 88%

    IMPROVEMENT IN STRUCTURAL STIMULATION*

    Biostimulators such as PLLA and CaHA are engineered to promote collagen and matrix support, contributing.

  • 85%

    OPTIMIZED REGENERATIVE SIGNALING*

    Exosome‑based and NAD+‑enhanced complexes aim to support cellular communication and energy pathways.

Figures represent targeted formulation parameters and internal development data, not individual patient outcomes. Products are intended for professional use within regulated markets, and performance may vary by protocol, technique, and complementary treatments.

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

Hyaluronic Acid

Exosome + NAD+

Exosome Hair

PLLA + CaHA

Lipolytic Body

PLLA + Calcium Hydroxyapatite

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

keep continue shopping

Not All Clinical Evaluation Follows the Same Standards

At ROVOCCI, we prioritize transparent methodology, scientific rigor, and practitioner‑focused evidence to support safe and effective use of our solutions.

ROVOCCI TYPICAL PRACTICE
QUANTITATIVE ASSESSMENT

When available, incorporates objective parameters (such as hydration levels, elasticity indices, or volumetric changes) alongside clinical observation.

May focus primarily on visual assessment without defined measurement endpoints.

SAFETY & TOLERABILITY

Solutions are developed with attention to biocompatibility, injection technique, and post‑procedure care, with systematic monitoring of tolerability in practice.

General safety checks performed, sometimes without standardized documentation of tolerability.

CLINICAL USE PANELS

Feedback collected from a network of practitioners treating diverse patient profiles, helping refine protocols and product positioning.

Smaller or informal user groups that may not fully represent real‑world clinical conditions.

PATIENT & USER PERCEPTION

Structured perception surveys may be used to capture satisfaction, comfort, and perceived improvement over time.

Unstructured feedback gathered without consistent scoring or follow‑up.

TRANSPARENCY

Clear communication of intended indications, mechanism of action concepts, and recommended protocols, with ongoing educational support.

Limited disclosure of evaluation approach and treatment rationale.